|
Market Closed -
NYSE
04:00:00 2026-11-13 pm EST
|
5-day change | 1st Jan Change | ||
| 0.9146 USD | -7.64% |
|
-10.33% | -45.23% |
| Market Cap | 233M 211M 196M 176M 333M 22B 344M 2.35B 932M 11.75B 876M 857M 37.31B | P/E 2026 * |
-18.3x | P/E 2027 * | -7.32x |
|---|---|---|---|---|---|
| Enterprise Value | 233M 211M 196M 176M 333M 22B 344M 2.35B 932M 11.75B 876M 857M 37.31B | EV / Sales 2026 * |
15.3x | EV / Sales 2027 * | 13.9x |
| Free-Float |
95.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
|
Boerse Muenchen
| BT3 | Real-time | |
|
Deutsche Boerse AG
| BT3 | Delayed | |
|
Börse Stuttgart
| BT3 | Delayed | |
|
Tradegate
| BT3 | Real-time |
Last Transcript: Lineage Cell Therapeutics, Inc.
| 1 day | -7.64% | ||
| 1 week | -10.33% | ||
| Current month | -8.54% | ||
| 1 month | -0.32% | ||
| 3 months | -14.52% | ||
| 6 months | -30.18% | ||
| Current year | -45.23% |
| 1 week | 0.89 |  | 1.13 |
| 1 month | 0.89 | | 1.13 |
| Current year | 0.88 | | 1.98 |
| 1 year | 0.88 | | 1.98 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 3.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 2018-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 2022-11-13 |
Priyantha Herath
CTO | Chief Tech/Sci/R&D Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 2009-06-30 |
Deborah Andrews
BRD | Director/Board Member | 68 | 2014-04-10 |
Michael Mulroy
CHM | Chairman | 60 | 2024-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Free | Director | 125,000 | 0.0501% | ||
| 7/1/26 | Broadwood Capital, Inc.
| Free | Company | 125,000 | 0.0501% | |
| 7/1/26 | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.64% | -10.33% | -51.35% | -9.45% | 233M | |
| -2.69% | -0.48% | +53.97% | +70.99% | 66.33B | |
| -0.92% | +7.67% | +12.64% | +92.55% | 60.62B | |
| 0.00% | +0.39% | +22.34% | +90.83% | 55.5B | |
| +0.14% | +2.35% | +13.86% | +106.64% | 47.58B | |
| -2.21% | -2.47% | +20.18% | +32.24% | 43.69B | |
| -2.30% | -10.40% | +154.30% | +725.54% | 37.27B | |
| +2.15% | +1.42% | +14.58% | +54.23% | 36.57B | |
| -2.32% | -2.24% | +76.50% | +54.55% | 32.22B | |
| +2.62% | +5.90% | -37.29% | +393.72% | 26.58B | |
| Average | -1.32% | -0.99% | +27.97% | +161.18% | 41B | |
| Weighted average by Cap. | -0.83% | +0.19% | +36.58% | +155.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.25M 13.82M 12.78M 11.53M 21.73M 1.44B 22.5M 154M 60.89M 768M 57.23M 56.02M 2.44B | 16.83M 15.26M 14.11M 12.73M 23.99M 1.59B 24.84M 170M 67.21M 848M 63.17M 61.83M 2.69B |
| Net income | -2.8M -2.54M -2.35M -2.12M -3.99M -264M -4.13M -28.19M -11.18M -141M -10.51M -10.28M -448M | -33.52M -30.38M -28.1M -25.35M -47.77M -3.16B -49.46M -338M -134M -1.69B -126M -123M -5.36B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-13 | $0.9146 | -7.64% | 2,078,264 |
| 26-11-12 | $0.9903 | -10.78% | 1,377,725 |
| 26-11-11 | $1.110 | +6.73% | 1,716,832 |
| 26-11-10 | $1.040 | -3.70% | 1,151,521 |
| 26-11-09 | $1.080 | +5.88% | 974,454 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
